TrialEuropean journal of clinical pharmacology2003

Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.

Gunnar Fager et al.PubMed ↗Publisher ↗

No numbers read from the abstract.